TAK-285

TAK-285 is a novel dual erbB protein kinase inhibitor specifically targeting human epidermal growth factor receptor (EGFR) and HER2.
Supplier Alfa Cytology
Product # BC0611
Pricing 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, inquire
Feedback